// App-Quantinova.ai

BSH19‐PO‐033 : The UK Myeloproliferative Neoplasm Registry for Myelofibrosis (UK‐MPN‐MF registry)

Researchers

Presenter

  • N.M. Butt

Principal Investigators

  • N. Curto-Garcia

  • J.-C. Ianotto

  • C. Harrison

  • A. Mead

Medical Centers

  • The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool

  • Guy’s and St. Thomas’ NHS Foundation Trust

  • Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Myelofibrosis with myeloid metaplasia

  • Myeloid neoplasms

  • Thrombocytopenia

  • Myelofibrosis

  • Venous thrombosis

  • Solid malignancies

Biomarkers

  • MPL proto-oncogene, thrombopoietin receptor

  • Calreticulin

  • Janus kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved